However, there is no evidence to support a robust correlation between CD5 cells and NACT response in patients with breast cancer. CD5-positivity correlates with tumor responses in blood malignancies, but this association does not appear to be as strong regarding NACT for breast cancer. This evidence concerns the gene CD5 and breast cancer.